TGF-β1 attenuates mediator release and de novo kit expression by human skin mast cells through a Smad-dependent pathway

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 7263-7272

  Zhao, Wei ^a   Gomez, Gregorio ^a   Yu, Shao Hua ^a   Ryan, John J ^b   Schwartz, Lawrence B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; SMAD PROTEIN; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1; CYTOKINE; IMMUNOGLOBULIN E RECEPTOR; PROSTAGLANDIN D2;

ARTICLE; CELL ACTIVATION; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MAST CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN CELL; STEM CELL; APOPTOSIS; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DEGRANULATION; GENE EXPRESSION; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL DEGRANULATION; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION; HUMANS; MAST CELLS; PROSTAGLANDIN D2; RECEPTORS, IGE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; SMAD PROTEINS; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 58149191873     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.7263     Document Type: Article

References (67)

1. Bischoff, S. C. 2007. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol. 7: 93-104.
2. Metz, M., and M. Maurer. 2007. Mast cells: key effector cells in immune responses. Trends Immunol. 28: 234-241. (Pubitemid 46654869)
3. Lu, L. F., E. F. Lind, D. C. Gondek, K. A. Bennett, M. W. Gleeson, K. Pino-Lagos, Z. A. Scott, A. J. Coyle, J. L. Reed, J. Van Snick, et al. 2006. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002.
4. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212. (Pubitemid 20149352)
5. Blume-Jensen, P., A. Siegbahn, S. Stabel, C. H. Heldin, and L. Ronnstrand. 1993. Increased Kit/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase C. EMBO J. 12: 4199-4209. (Pubitemid 23302034)
6. Blume-Jensen, P., L. Claesson-Welsh, A. Siegbahn, K. M. Zsebo, B. Westermark, and C. H. Heldin. 1991. Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J. 10: 4121-4128. (Pubitemid 21905443)
7. Valent, P., W. R. Sperr, L. B. Schwartz, and H. P. Horny. 2004. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J. Allergy Clin. Immunol. 114: 3-11. (Pubitemid 39005111)
8. Kitamura, Y., S. Hirota, and T. Nishida. 2001. A loss-of-function mutation of c-kit results in depletion of mast cells and interstitial cells of Cajal, while its gain-of-function mutation results in their oncogenesis. Mutat. Res. 477: 165-171. (Pubitemid 32480199)
9. Tsujimura, T., E. Morii, M. Nozaki, K. Hashimoto, Y. Moriyama, K. Takebayashi, T. Kondo, Y. Kanakura, and Y. Kitamura. 1996. Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice. Blood 88: 1225-1233. (Pubitemid 26276797)
10. Vandenbark, G. R., Y. Chen, E. Friday, K. Pavlik, B. Anthony, C. deCastro, and R. E. Kaufman. 1996. Complex regulation of human c-kit transcription by promoter repressors, activators, and specific myb elements. Cell Growth Differ. 7: 1383-1392.
11. Felli, N., L. Fontana, E. Pelosi, R. Botta, D. Bonci, F. Facchiano, F. Liuzzi, V. Lulli, O. Morsilli, S. Santoro, et al. 2005. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl. Acad. Sci. USA 102: 18081-18086. (Pubitemid 41798505)
12. Yee, N. S., H. Langen, and P. Besmer. 1993. Mechanism of kit ligand, phorbol ester, and calcium-induced down-regulation of c-kit receptors in mast cells. J. Biol. Chem. 268: 14189-14201. (Pubitemid 23195541)
13. Cruz, A. C., B. T. Frank, S. T. Edwards, P. F. Dazin, J. J. Peschon, and K. C. Fang. 2004. Tumor necrosis factor-α-converting enzyme controls surface expression of c-kit and survival of embryonic stem cell-derived mast cells. J. Biol. Chem. 279: 5612-5620.
14. Yee, N. S., C. W. Hsiau, H. Serve, K. Vosseller, and P. Besmer. 1994. Mechanism of down-regulation of c-kit receptor: roles of receptor tyrosine kinase, phosphatidylinositol 3′-kinase, and protein kinase C. J. Biol. Chem. 269: 31991-31998. (Pubitemid 24379578)
15. Shimizu, Y., L. K. Ashman, Z. Du, and L. B. Schwartz. 1996. Internalization of kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of kit. J. Immunol. 156: 3443-3449. (Pubitemid 26123559)
16. Blobe, G. C., W. P. Schiemann, and H. F. Lodish. 2000. Role of transforming growth factor β in human disease. N. Engl. J. Med. 342: 1350-1358. (Pubitemid 30408720)
17. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16: 137-161.
18. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
19. Chin, D., G. M. Boyle, P. G. Parsons, and W. B. Coman. 2004. What is transforming growth factor-β (TGF-β)? Br. J. Plast. Surg. 57: 215-221. (Pubitemid 38380437)
20. Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29: 117-129. (Pubitemid 32952643)
21. Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425: 577-584. (Pubitemid 37280136)
22. Xu, L., Y. Kang, S. Col, and J. Massague. 2002. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGF-β signaling complexes in the cytoplasm and nucleus. Mol. Cell 10: 271-282. (Pubitemid 35007342)
23. Kavsak, P., R. K. Rasmussen, C. G. Causing, S. Bonni, H. Zhu, G. H. Thomsen, and J. L. Wrana. 2000. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation. Mol. Cell 6: 1365-1375. (Pubitemid 32045929)
24. Ebisawa, T., M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, T. Imamura, and K. Miyazono. 2001. Smurf1 interacts with transforming growth factor-βtype I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276: 12477-12480.
25. Massague, J. 2000. How cells read TGF-β signals. Nat. Rev. Mol. Cell Biol. 1: 169-178.
26. Deaton, R. A., C. Su, T. G. Valencia, and S. R. Grant. 2005. Transforming growth factor-β1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J. Biol. Chem. 280: 31172-31181.
27. Engel, M. E., M. A. McDonnell, B. K. Law, and H. L. Moses. 1999. Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J. Biol. Chem. 274: 37413-37420.
28. Yakymovych, I., P. ten Dijke, C. H. Heldin, and S. Souchelnytskyi. 2001. Regulation of Smad signaling by protein kinase C. FASEB J. 15: 553-555.
29. Kim, Y. K. 2007. TGF-β1 induction of p21WAF1/cip1 requires smad-independent protein kinase C signaling pathway. Arch. Pharm. Res. 30: 739-742.
30. Chow, J. Y., H. Dong, K. T. Quach, P. N. Van Nguyen, K. Chen, and J. M. Carethers. 2008. TGF-β mediates PTEN suppression and cell motility through calcium-dependent PKC-α activation in pancreatic cancer cells. Am. J. Physiol. 294: G899-G905.
31. Miller, H. R., S. H. Wright, P. A. Knight, and E. M. Thornton. 1999. A novel function for transforming growth factor-β1: up-regulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific β-chymase, mouse mast cell protease-1. Blood 93: 3473-3486.
32. Wright, S. H., J. Brown, P. A. Knight, E. M. Thornton, P. J. Kilshaw, and H. R. Miller. 2002. Transforming growth factor-β1 mediates coexpression of the integrin subunit αE and the chymase mouse mast cell protease-1 during the early differentiation of bone marrow-derived mucosal mast cell homologues. Clin. Exp. Allergy 32: 315-324.
33. Funaba, M., T. Ikeda, M. Murakami, K. Ogawa, Y. Nishino, K. Tsuchida, H. Sugino, and M. Abe. 2006. Transcriptional regulation of mouse mast cell protease-7 by TGF-β. Biochim. Biophys. Acta 1759: 166-170.
34. Funaba, M., T. Ikeda, M. Murakami, K. Ogawa, and M. Abe. 2005. Up-regulation of mouse mast cell protease-6 gene by transforming growth factor-β and activin in mast cell progenitors. Cell. Signal. 17: 121-128.
35. Funaba, M., K. Nakaya, T. Ikeda, M. Murakami, K. Tsuchida, and H. Sugino. 2006. Requirement of Smad3 for mast cell growth. Cell. Immunol. 240: 47-52.
36. Broide, D. H., S. I. Wasserman, J. Alvaro-Gracia, N. J. Zvaifler, and G. S. Firestein. 1989. Transforming growth factor-β1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation. J. Immunol. 143: 1591-1597.
37. Toyota, N., Y. Hashimoto, S. Matsuo, and H. Iizuka. 1995. Transforming growth factor β1 inhibits IL-3- and IL-4-dependent mouse connective tissue-type mast cell proliferation. Arch. Dermatol. Res. 287: 198-201.
38. Kashyap, M., D. P. Bailey, G. Gomez, J. Rivera, T. F. Huff, and J. J. Ryan. 2005. TGF-β1 inhibits late-stage mast cell maturation. Exp. Hematol. 33: 1281-1291. (Pubitemid 41540516)
39. Norozian, F., M. Kashyap, C. D. Ramirez, N. Patel, C. L. Kepley, B. O. Barnstein, and J. J. Ryan. 2006. TGFβ1 induces mast cell apoptosis. Exp. Hematol. 34: 579-587.
40. Mekori, Y. A., and D. D. Metcalfe. 1994. Transforming growth factor-β prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation. J. Immunol. 153: 2194-2203.
41. Anthoni, M., G. Wang, C. Deng, H. J. Wolff, A. I. Lauerma, and H. T. Alenius. 2007. Smad3 signal transducer regulates skin inflammation and specific IgE response in murine model of atopic dermatitis. J. Invest. Dermatol. 127: 1923-1929.
42. Gomez, G., C. D. Ramirez, J. Rivera, M. Patel, F. Norozian, H. V. Wright, M. V. Kashyap, B. O. Barnstein, K. Fischer-Stenger, L. B. Schwartz, et al. 2005. TGF-β1 inhibits mast cell FcεRI expression. J. Immunol. 174: 5987-5993. (Pubitemid 40663785)
43. Olsson, N., E. Piek, P. ten Dijke, and G. Nilsson. 2000. Human mast cell migration in response to members of the transforming growth factor-β family. J. Leukocyte Biol. 67: 350-356.
44. Wiener, Z., B. Kohalmi, P. Pocza, J. Jeager, G. Tolgyesi, S. Toth, E. Gorbe, Z. Papp, and A. Falus. 2007. TIM-3 is expressed in melanoma cells and is upregulated in TGF-β stimulated mast cells. J. Invest. Dermatol. 127: 906-914.
45. Nilsson, G., T. Blom, M. Kusche-Gullberg, L. Kjellen, J. H. Butterfield, C. Sundstrom, K. Nilsson, and L. Hellman. 1994. Phenotypic characterization of the human mast-cell line HMC-1. Scand. J. Immunol. 39: 489-498.
46. Butterfield, J. H., D. Weiler, G. Dewald, and G. J. Gleich. 1988. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Res. 12: 345-355.
47. Zhao, W., C. L. Kepley, P. A. Morel, L. M. Okumoto, Y. Fukuoka, and L. B. Schwartz. 2006. FcγRIIa, not FcγRIIb, is constitutively and functionally expressed on skin-derived human mast cells. J. Immunol. 177: 694-701.
48. Gebhardt, T., A. Lorentz, F. Detmer, C. Trautwein, H. Bektas, M. P. Manns, and S. C. Bischoff. 2005. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor β1. Gut 54: 928-934.
49. Riske, F., J. Hakimi, M. Mallamaci, M. Griffin, B. Pilson, N. Tobkes, P. Lin, W. Danho, J. Kochan, and R. Chizzonite. 1991. High affinity human IgE receptor (FcεRI): analysis of functional domains of the α-subunit with monoclonal antibodies. J. Biol. Chem. 266: 11245-11251.
50. Kambe, N., M. Kambe, J. P. Kochan, and L. B. Schwartz. 2001. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood 97: 2045-2052.
51. Irani, A. M., T. R. Bradford, C. L. Kepley, N. M. Schechter, and L. B. Schwartz. 1989. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J. Histochem. Cytochem. 37: 1509-1515.
52. Schwartz, L. B., R. A. Lewis, D. Seldin, and K. F. Austen. 1981. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J. Immunol. 126: 1290-1294.
53. Schwartz, L. B., K. F. Austen, and S. I. Wasserman. 1979. Immunologic release of β-hexosaminidase and β-glucuronidase from purified rat serosal mast cells. J. Immunol. 123: 1445-1450.
54. Zhao, W., C. A. Oskeritzian, A. L. Pozez, and L. B. Schwartz. 2005. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J. Immunol. 175: 2635-2642.
55. Irani, A. A., N. M. Schechter, S. S. Craig, G. DeBlois, and L. B. Schwartz. 1986. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA 83: 4464-4468.
56. Oskeritzian, C. A., W. Zhao, H. K. Min, H. Z. Xia, A. Pozez, J. Kiev, and L. B. Schwartz. 2005. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J. Allergy Clin. Immunol. 115: 1162-1168.
57. Valent, P., J. Besemer, C. Sillaber, J. H. Butterfield, R. Eher, O. Majdic, K. Kishi, W. Klepetko, F. Eckersberger, K. Lechner, and P. Bettelheim. 1990. Failure to detect IL-3-binding sites on human mast cells. J. Immunol. 145: 3432-3437.
58. + pluripotent progenitor cells. J. Immunol. 148: 772-777.
59. Ekoff, M., A. Strasser, and G. Nilsson. 2007. FcεRI aggregation promotes survival of connective tissue-like mast cells but not mucosal-like mast cells. J. Immunol. 178: 4177-4183.
60. Xiang, Z., C. Moller, and G. Nilsson. 2006. IgE-receptor activation induces survival and Bfl-1 expression in human mast cells but not basophils. Allergy 61: 1040-1046. (Pubitemid 44175210)
61. Perlman, R., W. P. Schiemann, M. W. Brooks, H. F. Lodish, and R. A. Weinberg. 2001. TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell Biol. 3: 708-714. (Pubitemid 32734248)
62. 1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation. Proc. Natl. Acad. Sci. USA 96: 1427-1432.
63. Sanchez Mejia, R. O., B. K. Lam, and J. P. Arm. 2000. Matrix-associated transforming growth factor-β1 primes mouse bone marrow-derived mast cells for increased high-affinity Fc receptor for immunoglobulin E-dependent eicosanoid biosynthesis. Am. J. Respir. Cell Mol. Biol. 22: 557-565.
64. Miyazawa, K., K. Toyama, A. Gotoh, P. C. Hendrie, C. Mantel, and H. E. Broxmeyer. 1994. Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down-modulation in M07e cells. Blood 83: 137-145. (Pubitemid 24016525)
65. Broudy, V. C., N. L. Lin, H. J. Buhring, N. Komatsu, and T. J. Kavanagh. 1998. Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer. Blood 91: 898-906. (Pubitemid 28078292)
66. Heinrich, M. C., D. C. Dooley, and W. W. Keeble. 1995. Transforming growth factor β1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood 85: 1769-1780.
67. Blume-Jensen, P., C. Wernstedt, C. H. Heldin, and L. Ronnstrand. 1995. Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells. J. Biol. Chem. 270: 14192-14200.